The use of cyclophosphamide as an enhancer of the vaccine against foot-and-mouth disease.
Experientia
; 52(6): 605-7, 1996 Jun 15.
Article
em En
| MEDLINE
| ID: mdl-8698098
The immunization of biungulate animals with killed foot-and-mouth disease virus (FMDV) requires periodic vaccinations due to a low vaccine immunogenicity. Therefore, FMDV antigens need to be combined with adjuvants such as aluminium hydroxide, saponin or oil emulsions. Animal handling for periodic inoculations, and the repeated doses of vaccines that have to be administered increase the commercialization costs. Moreover, the use of adjuvants may induce adverse effects. In the present work we show that it is possible to increase the life span of neutralizing antibodies in serum when a single dose of cyclophosphamide (Cy) is administered four days before vaccination with aluminium hydroxidesaponin FMDV vaccine.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Vacinas Virais
/
Doenças dos Bovinos
/
Aphthovirus
/
Ciclofosfamida
/
Febre Aftosa
/
Imunossupressores
Limite:
Animals
Idioma:
En
Revista:
Experientia
Ano de publicação:
1996
Tipo de documento:
Article
País de afiliação:
Argentina
País de publicação:
Suíça